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Abstract Phytochemical investigations of the ethanolic extract of leaves of Clutia lanceolata (Family: Euphorbiaceae)
resulted in the isolation of four compounds viz. 3,4-dihydroxy-2-methylbenzoic acid (1), 2,20-dihydroxy-1,10-binaphthyl
(2), 1,3,8-trihydroxy-6-methylanthracene-9,10-dione (3) and 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-
trien-3-one (4). Although all the isolated compounds were known but this was the first report from this plant source. Their
structures were established on the basis of chemical and physical evidences viz. elemental analysis, FT-IR, 1H-NMR, 13C-
NMR and mass spectral analysis. Structure of compound 2 and 4 was further authenticated by single-crystal X-ray analysis
and density functional theory calculations. The isolated compounds (1–4) were screened for AChE enzyme inhibition assay
in which compound 3 and 4 were found to be more potent AChE inhibitor. Molecular docking study of potent AChE
inhibitor was performed to find the probable binding mode of the compounds into the active site of receptor. Moreover, the
isolated compounds were also screened for in vivo cytotoxicity by brine shrimp lethality assay.
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1 Introduction
Clutia is a genus of plants belongs to the family Euphor-
biaceae and is native to sub-Saharan Africa and the Ara-
bian Peninsula. Ethnobotanical studies have uncovered
several Clutia species which are widely used in folk
medicine and have potential medicinal value [1]. The
phytochemical constituents of the genus Clutia have not
been investigated extensively, only few species have been
explored phytochemically viz C. richardiana [2–7], C.
abyssinica [8–10], C. robusta [11] and C. similis [12] etc.
In this context, Clutia lanceolata, a woody herb or shrub or
sometime grown up to tree belonging to the family
Euphorbiaceae, is also relatively unexplored. Baka in 2010
showed the antifungal property of the aqueous extracts of
its leaves [13] and Mossa et al. reported the hypoglycaemic
property of C. lanceolata [14]. As part of our research
work to explore the phytochemical and biological profile of
medicinal plants [15, 16], we have carried out the phyto-
chemical analysis of the leaves of C. lanceolata. The pre-
sent paper reported the isolation, characterization, X-ray
crystallographic study and biological activity of four
compounds i.e. 3,4-dihydroxy-2-methylbenzoic acid (1),
2,20-dihydroxy-1,10-binaphthyl (2), 1,3,8-trihydroxy-6-
methylanthracene-9,10-dione, Emodin (3) and 5-hydroxy-
1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one,
curcumin (4), isolated from the ethanolic extract of C.
lanceolata leaves (Fig. 1). The structure of all the isolated
phytoconstituents was established on the basis of physical
and chemical data (IR, 1H-NMR, 13C-NMR, and MS
spectral analysis). However, the structure of compounds 2
and 4 was further authenticated with X-ray crystallographic
analysis. To the best of our knowledge, these four com-
pounds have not been reported from this plant source.
Moreover, compound 2 was isolated from the only natural
source i.e. the root of Sesbania grandiflora by Noviany
et al. [17].
2 Results and Discussion
2.1 Structural Elucidation
Compound 1 was isolated as brick red crystalline solid, mp
233–235 C. Elemental analysis along with the molecular
ion peak at m/z 168.04 [M]? agreed with the molecular
formula C8H8O4. The IR spectrum revealed characteristic
absorption bands for hydroxyl group (3336 cm-1) and
phenyl ring (1608 and 1489 cm-1). The presence of phe-
nolic -OH group was further confirmed with the positive
ferric chloride test. The IR spectrum also showed absorp-
tion bands at 3463 and 1685 cm-1 corresponded to car-
boxyl group which was further confirmed by the
appearance of effervescences with NaHCO3. The
1H NMR
spectrum indicated the presence of two ortho coupled
doublets at d 7.74 and 6.75 corresponding to the H-6 and
H-5 aromatic protons, respectively. The downfield shift of
proton H-6 is due to the presence of carboxylic group on
adjacent carbon. The presence of two singlets at d 10.06
and 9.67 integrating for two and one proton was corre-
sponded to the two phenolic -OH and a carboxylic -OH,
respectively. Moreover, a sharp singlet at d 2.24 integrating
for three protons indicates the presence of methyl group.
The 13C NMR spectrum exhibited peaks at d 13.75 and
Compound 1 Compound 2 Compound 3
Compound 4
Fig. 1 Structure of isolated
compounds (1–4) from Clutia
lanceolata
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178.43 which correspond to the presence of methyl and
carbonyl carbon, respectively. Further, peaks at d 148.0 (C-
1), 128.3 (C-2), 158.60 (C-3), 158.69 (C-4), 127.98 (C-5)
and 114.90 (C-6) showed the presence of six carbons of
aromatic ring. In the light of above assignment and by
comparing their spectral data and melting points with the
reported literature [18], it was concluded that the com-
pound 1 is 3,4-dihydroxy-2-methylbenzoic acid.
Compound 2 was obtained as white crystals, mp 207 C
with a molecular formula of C20H14O2 deduced from the
positive ion ESIMS at m/z 286.10 [M]?. Elemental analysis
was also in good agreement with the molecular formula
C20H14O2. The UV spectrum of the compound exhibited
characteristic absorption band for aromatic nucleus dis-
playing kmax at 227, 278 and 336 nm indicating the presence
of a phenolic chromophore. The IR spectrum showed
absorptions at 3425 cm-1 indicating -OH group, at
3028 cm-1 for aromatic C–H stretching and
1380–1615 cm-1 for C=C stretching of aromatic rings. The
positive response of compound to ferric chloride specifies
the phenolic nature of hydroxyl group. The 1H NMR spec-
trum displayed a singlet at d 11.15 integrating for two pro-
tons corresponded to two hydroxyl group. Two independent
ortho-coupled doublets with J = 9 Hz at d 7.24 and 7.85
integrating for two protons each corresponded to the H-3/30
and H-4/40 protons of the A ring of naphthalene. The H-5/50
and H-8/80 protons of B ring displayed double doublets with
J = 1.3 and 8.0 Hz at d 7.94 and 7.12, respectively. There
were two 3fold doublets at d 7.38 and 7.44 corresponded to
the remaining protons H-6/60 and H-7/70 of the naphthyl ring
B exhibiting two ortho-couplings (J = 8.0 and 7.0 Hz) and
onemeta-coupling (J = 1.3 Hz) doublets, characteristics for
the naphthyl ring. The 13C NMR spectrum displayed char-
acteristic peaks of naphthyl ring integrating around at d
118.4–133.9. However, the carbon of the connected naphthyl
rings showed peaks at d 110.8 and the carbon with hydroxyl
group substitution displayed peak at d 154.8. In the light of
above data it was significantly concluded that compound 2 is
2,20-dihydroxy-1,10-binaphthyl [17]. The structure of com-
pound 2 was further authenticated with the X-ray crystallo-
graphic analysis.
Compound 3 was isolated as orange coloured solid with
mp of 267–269 C. Elemental analysis along with the
molecular ion peak at m/z 270.05 [M]? agreed with the
molecular formula C15H10O5. The compound responded
positively to the ferric chloride test indicating the presence of
phenolic –OHgroup, which further confirmedwith the broad
peak at 3510 cm-1 in the IR spectrum. The IR spectrum also
displayed peak at 3056 and 2918 cm-1 corresponded to
aromatic and aliphatic C–H stretching vibrations. However,
peaks at 1676 and 1625 cm-1 corresponded toC=O andC=C
bonds of a,b-unsaturated carbonyl functionality. The 1H
NMR spectrum of compound showed four meta-coupled
doublets at d 7.81, 7.65, 7.30 and 7.09 corresponded to
aromatic protons H-2, H-4, H-7 and H-5, respectively. Sin-
glet at d 12.13 and 12.02 integrating for two and one protons,
respectively, corresponded to hydroxyl protons. Moreover,
sharp singlet at d 2.46 integrating for three protons was
assigned to methyl protons. The 13C NMR spectrum exhib-
ited peak for carbonyl carbons at d 182.0 (C-9) and 192.5 (C-
10), methyl carbon at d 22.2, methyl substituted carbons at d
149.3 (C-3) and for hydroxyl substituted carbons at d 162.4
(C-1), 160.3 (C-6) and 162.6 (C-8). The spectrum also
showed eight more peaks for aromatic carbons at d 113.7 (C-
8a), 121.3 (C-7), 119.9 (C-5), 133.8 (C-5a), 124.5 (C-4),
134.0 (C-4a), 136.9 (C-2) and 111.8 (C-1a). In the light of
above data it was significantly concluded that compound 3 is
1,3,8-trihydroxy-6-methylanthracene-9,10-dione (Emo-
din) [19].
Compound 4 was furnished as shining light orange
coloured crystals with mp 177 C. Elemental analysis
along with the molecular ion peak at m/z 368.13 [M]?
were in good agreement with the molecular formula
C21H20O6. The IR spectrum showed characteristics peak
for -OH at 3427 cm-1, aromatic and aliphatic C–H
vibrations at 3065 and 2905 cm-1, respectively. The
absorption peaks at 1682, 1480–1605 and 1120 cm-1
corresponded to C=O, C=C and C–O bands, respectively.
The 1H NMR spectrum exhibited doublets at d 7.58, 7.22,
6.65 and 6.51 corresponded to H-1, H-2, H-6 and H-7,
respectively. However, a sharp singlet at 6.72 was assigned
to H-4 proton. The broad singlet at d 11.12 and 10.75 were
assigned to phenolic and enolic hydroxy groups, respec-
tively. The aromatic protons of compound 4 showed ortho-
coupled doublets at d 6.92, 6.81 and singlet at d 7.10
integrating for two protons each corresponded to H-50/500,
H-60/600 and H-20/200, respectively. The methoxy group
showed singlet at d 3.85 integrating for six protons. The
13C NMR spectrum exhibited peaks for aromatic carbons at
d 111.2, 116.5, 121.9, 127.8, 147.3 and 149.6 corresponded
to C-20/200, C-50/500, C-60/600, C-10/100, C-30/300 and C-40/400,
respectively. Moreover, the straight chain of compound
showed peak at d 142.3 and 124.8 for C-1 and C-2, 140.7
and 122.2 for C-7 and C-6, respectively. However, C-3,
C-4 and C-5 displayed peaks at d 182.4, 100.1 and 180.3,
respectively. In light of the above discussion and with
comparison of the data to the reported literature [20], it was
concluded that compound 4 is 5-hydroxy-1,7-bis(4-hy-
droxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one i.e. Cur-
cumin. The structure of compound 4 was also authenticated
by X-ray crystallographic analysis.
2.2 Crystal Structure of Compound 2 and 4
Compound 2 and 4, once isolated were found to be air-
stable and soluble in all common organic solvents but
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insoluble in water. X-ray crystallographic analysis revealed
that compound 2 crystallized in the orthorhombic structure
with Iba2 space group, while compound 4 crystallized in
monoclinic crystal system with space group P2/n. These
single crystal X-ray diffraction analysis of compounds 2
and 4 were in good agreement with the previous reports
[21–23]. Asymmetric unit of compound 2 and 4 with the
ellipsoids drawn at the 50 % probability level was shown
in Figs. 2 and 3, respectively. The crystal data and structure
refinement parameters were summarized in Table 1. The
bond lengths and bond angles of compound 2 and 4 were
presented in Tables 2 and 3. The crystal structure of
compound 2 was stabilised by the intermolecular (O–
H…O) hydrogen bonding. The bond length of O1-C2 and
O2-C12 was 1.375 and 1.351 A˚, respectively, showed
partial double bond character due to the conjugation of lone
pair of electrons of oxygen with naphthalene ring. The
bond length between two naphthalene rings i.e. C1–C11
was 1.496 A˚. The dihedral angle between two naphthalene
rings C2-C1-C11 and C1-C11-C12 were 120.2(4)o and
118.8(4)o, respectively. The crystal structure of compound
4 was stabilised by intramolecular (O–H…O) hydrogen
bonding between O1H…O5, O4H…O6 and O3H…O2 and
intermolecular (O–H…O and C–H…O) hydrogen bonds
involving atoms O1H and H13 with atoms O3 and O5. The
C–O bond lengths of O1-C2, O4-C17, O5-C1 and O6-C18
are in order of 1.36 A˚ less than typical single C–O bonds as
the lone pair of electron of oxygen comes in conjugation
with benzene ring and thus the C–O bonds attain partial
double bond character. However, the bond length of O5-
C23 and O6-C21 were in order of 1.41 A˚ and O2-C9 and
O3-C11 had 1.29 and 1.28 A˚, respectively. The C8–C9 and
C11-C12 showed single bond character with bond length of
1.45 A˚. However, C9–C10 and C10–C11 showed partial
double band character with bond length of 1.38 and 1.40 A˚.
The angles of C8/C9/C10, C9/C10/C11 and C10/C11/C12
were 121.39(12)o, 120.62(12)o and 124.30(13)o, respec-
tively. The dihedral angles of C6/C5/C7/C8 and C12/C13/
C14/C19 were -4.6(2)o and 24.7(2)o, respectively.
2.3 DFT Results of Compounds 2 and 4
To examine the influence of the intermolecular interactions
on the molecular geometries we have performed DFT
calculations of the equilibrium geometries of the free
molecules starting with the experimental X-ray geometries.
For the compound 2, there was a good agreement between
the experimental and calculated geometries (Table 2;
Fig. 4) with the largest difference occurring in the torsion
angle C2-C1-C11-C12 (7.38), however this was not unex-
pected, since the rotation around a C–C single bond did not
have a high energy cost [24]. The situation was quite dif-
ferent for compound 4. In the experimental geometry, there
was a high degree of chemical symmetrization in the enol
ring, defined as near equality of the C–C and C–O bond
lengths compared pairwise, according to Herbstein et al.
[25]. The theoretical geometry did not display this sym-
metrization. One possible explanation for this discrepancy
may be the O–H…O hydrogen bonds involving the oxygen
atoms of the enol ring and hydroxyl groups, that linked
different curcumin molecules (Table 3; Fig. 5).
2.4 AChE Inhibition Results
The acetylcholinesterase inhibition effect of the isolated
compounds (1–4) was assessed by Ellman’s spectrophoto-
metric method using human recombinant AChE with
tacrine as reference compound. The result obtained has
been summarized in Table 4. It can be inferred from the
data shown in Table 4, that compound 3, exhibited the
strongest inhibition to AChE with an IC50 value of
14.2 lM, followed by compound 4 (IC50 = 16.4 lM), 2
(IC50 = 21.9 lM) and 1 (IC50 = 23.7 lM). The results
indicated that all the isolated compounds displayed mod-
erate inhibitory activity against the acetylcholinesterase
enzyme. However, compounds 3 and 4 were found to be
more active in comparison to 1 and 2. This was mainly
attributed to the basic skeleton of compound 3 and 4 which
provide them more binding prospects with the formation of
hydrogen bonding interactions to the amino acid residues
of the protein. However, the p–p stacking may also leads to
improve its activity with the formation of additional non-
bonding interactions to the protein.
2.5 Molecular Docking Studies
The molecular docking studies were conducted in order to
get insight the binding pattern and extent of binding of
compounds with the target enzymes. In the present study,
Fig. 2 Asymmetric unit of compound 2 with the ellipsoids drawn at
the 50 % probability level
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we have carried out the docking study of the two most
potent acetylcholinestrerase inhibitor i.e. compounds 3 and
4 of the isolated compounds in order to anticipate the
binding mode towards target enzyme (PDB: 1EVE) and to
give justification for the observed in vitro AChE inhibition
property of the isolated compounds 3 and 4. The in silico
docking experiment for compounds 3 and 4 against the
X-ray crystal structure of receptor (PDB: 1EVE), was
Fig. 3 Asymmetric unit of
compound 4 with the ellipsoids
drawn at the 50 % probability
level
Table 1 Crystal data and structure refinements of compound 2 and 4
Compound 2 Compound 4
Empirical formula C20H14O2 C21H20O6
Formula weight 286.31 368.37
Temperature 293(2) K 293(2) K
Wavelength 0.71073 A˚ 0.71073 A˚
Crystal system Orthorhombic Monoclinic
Space group Iba2 P2/n
a 21.5986(8) A˚ 12.6851(5) A˚
b 15.6844(6) A˚ 7.1848(3) A˚




Volume 2921.58(19) A˚3 1805.71(13) A˚3
Z 8 4
Density (calculated) 1.302 gcm-3 1.355 gcm-3
Absorption coefficient 0.083 mm-1 0.099 mm-1
Extinction coefficient 0.0052(12) –
F(000) 1200 776
Crystal size 0.53 9 0.48 9 0.24 mm3 0.60 9 0.46 9 0.44 mm3
h range for data collection 3.11–25.848 1.99–29.738
Index ranges -26\ h\ 26; -19\ k\ 19; -10\ l\ 10 -17\ h\ 13; -10\ k\ 10; -27\ l\ 27
Reflections collected 24389 39945
Independent reflections 2832 5076
Completeness to 2h = 508 99.8 % 98.8 %
Refinement method Full matrix LS on F2 Full matrix LS on F2
Data/restrains/parameters 2832/1/206 5076/0/255
Goodness-of-fit on F2 1.104 1.033
Final R indices [I[ 2r(I)] R = 0.0487; wR = 0.1170 R = 0.0487; wR = 0.1408
R indices (all data) R = 0.0781; wR = 0.1480 R = 0.0648; wR = 0.1570
Largest diff. peak and hole 0.163 and -0.204 0.342 and -0.301
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carried out using PATCHDOCK and iGEMDOCK soft-
ware. Docking simulations showed comparable binding
affinity of compounds 3 and 4 with AChE enzyme. Several
interactions from the docking pose were observed notably
TYR121; SER122; LEU127; TYR130; GLU199; SER200;
PHE330; PHE331 and HIS440 between the receptor and
compound 3; SER 122; SER226; CYS231; TRP233;
PHE288; VAL323; LEU404 and HIS440 between the
receptor and compound 4 in proper binding orientations.
The binding score from iGEMDOCK was found to be
-108.18 and -98.91 kcal/mol for compounds 3 and 4,
respectively. This is due to the cumulative van der Wall
contribution and H-bonding interactions. The docking
studies revealed that the aromatic ring also plays a major
role in stabilizing the ligand-receptor complex by pi-cation
interactions with amino acid residue of the target protein as
shown in Fig. 6. These strong interactions help the com-
pounds to bury well inside the cavity of target protein and
acts as a potent AChE inhibitor. The analysis of enzyme
inhibition data obtained from the in vitro experiments,
showed the comparative inhibitory property of compound 3
(IC50 = 14.2 lM) and compound 4 (IC50 = 16.4 lM) and
found to be moderately potent compared to a standard drug
tacrine (IC50 = 0.20 lM), as AChE inhibitor. The HB plot
of the interacted residues in protein of AChE with com-
pounds 3 and 4 was depicted in Fig. 7. This plot helped us
to study the way protein residues interacts with ligand.
2.6 Cytotoxicity Studies
The in vivo cytotoxicity of compounds (1–4) isolated from
the leaves of C. lanceolata was evaluated to brine shrimp
nauplii using vincristine sulfate as standard (Fig. S1 ESI).
It is one of the most convenient methods to determine the
cytotoxicity of any compound. The LD50 value of com-
pounds was reported in ppm units and summarized in
Table 5. In the present study the LD50 value of the com-
pounds were found to be 23.40 lg/mL (compound 1),
17.78 lg/mL (compound 2), 13.80 lg/mL (compound 3)
and 11.66 lg/mL (compound 4) as compared to the
Table 2 Comparison of selected geometrical parameters for com-















Table 3 Comparison of selected geometrical parameters for com-


























Fig. 4 Comparison of the molecular conformation of compound 2, as
established from the X-ray study (red) with the optimized geometry
(blue). (Software used for visualization: VMD, version 1.9.1, January
29, 2012 [24])
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standard drug vincristine sulfate whose LD50 was found to
be 8.84 lg/mL. These data clearly signified the consider-
able cytotoxicity of all the isolated compounds (1–4).
However, compound 4 showed most lethality to the brine
shrimp than the other isolated compounds 1–3, almost
comparable to the standard drug.
3 Experimental Section
3.1 General Experimental Procedures
All solvents and chemicals were purchased from com-
mercial sources (Sigma-Aldrich, Merck, and others) and
used as received or dried using standard procedures.
Melting points were determined on a Kofler apparatus and
are uncorrected. Elemental analysis (CHN) has been con-
ducted using a Thermo Scientific (FLASH 2000) CHN
Elemental Analyser. Fourier transform-infrared (FT-IR)
spectra were recorded using a Perkin-Elmer (2000 FTIR)
Spectrometer by the KBr pellet method, values are given in
cm-1. The UV spectra were recorded with PerkinElmer
UV Win Lab spectrophotometer. 1H and 13C NMR spectra
were run in CDCl3 and DMSO-d6 on Bruker Avance-II 400
and 100 MHz instruments, respectively. Mass spectra were
recorded on a JEOL D-300 mass spectrometer. Thin-layer
chromatography (TLC) glass plates were coated with silica
gel (E-Merck G254) and exposed to iodine vapour to check
the purity of the isolated compounds.
3.2 Plant Materials
The leaves of C. lanceolata were collected from Abha
region of South of Saudi Arabia and identified by Dr.
S. Adeen, Taxonomist of the Medicinal, Aromatic and
Poisonous Plant Research Centre (MAPPRC), College of
Pharmacy, King Saud University, Riyadh, Saudi Arabia. A
voucher specimen bearing number 14077 has been depos-
ited in their herbarium.
3.3 Extraction and Isolation
The air-dried leaves of C. lanceolata were crushed to make
powder (2.0 kg) and extracted exhaustively with 95 % ethanol
about three times under reflux temperature and filtered to yield a
filtrate. The solvent was evaporated under reduced pressure to
afford a crude extract and fractionated successively with petro-
leum ether, benzene, ethyl acetate andmethanol. The petroleum
ether and benzene extracts showed similar behaviour on TLC
hence were mixed together. The mixed petroleum ether and
benzene extract was chromatographed on a silica gel column,
eluting stepwise with petroleum ether-benzene (1:0, 9:1? 1:9)
which afforded compounds 1 and 2. Similarly, the ethyl acetate
extracts was subjected to column chromatography on silica gel,
eluting stepwisewithbenzene-ethyl acetate (1:0,9:1 ? 1:9, 0:1)
which furnished two compounds i.e. compounds 3 and 4. The
isolated compounds were purified by repeated column chro-
matography followed by crystallization to get pure compounds.
3.4 Spectral Characterization of Isolated Compounds
3.4.1 3,4-Dihydroxy-2-methylbenzoic acid (1)
Brick red crystalline solid; mp 233–235 C; IR (KBr) tmax
3463, 3336, 3184, 1685, 1608, 1489, 1431, 1264, 1228,
Fig. 5 Comparison of the
molecular conformation of
compound 4, as established
from the X-ray study (red) with
the optimized geometry (blue).
(Software used for
visualization: VMD, version
1.9.1, January 29, 2012 [24])
Table 4 In vitro AChE inhibition IC50 (lM) of compounds 1–4 and
reference drug tacrine
S. no. Compounds IC50 (lM)
a ± SEM for
hAChE inhibition
1 Compound 1 23.7 ± 0.02
2 Compound 2 21.9 ± 0.05
3 Compound 3 14.2 ± 0.06
4 Compound 4 16.4 ± 0.03
5 Tacrine (standard) 0.20 ± 0.01
a IC50 = Concentration of inhibitor required to decrease enzyme
activity by 50 %
Acetylcholinesterase and Cytotoxic Activity of Chemical Constituents 273
123
1173, 1089, 827 cm-1; 1H NMR (DMSO d6, 400 MHz) d
10.06 (2H, s, 2 9 –OH), 9.67 (1H, s, -COOH), 7.74 (1H,
d, J = 8.0 Hz, H-6), 6.75 (1H, d, J = 8.0 Hz, H-5), 2.24
(3H, s, –CH3);
13C NMR (DMSO d6,100 MHz) d 178.4 (C,
COOH), 158.6 (C, C-3), 158.6 (C, C-4), 148.0 (C, C-1),
128.3 (C, C-2), 127.9 (CH, C-5), 114.9 (CH, C-6), 13.7 (–
CH3); ESIMS m/z 168.04 [M]
? (C8H8O4); Anal. Calc. for
C8H8O4: C, 57.14; H, 4.80; found: C, 58.09; H, 4.95.
3.4.2 2,20-Dihydroxy-1,10-binaphthyl (2)
White crystals; mp 207 C; UV (MeOH) kmax 227, 278,
336 nm; IR (KBr) tmax 3425, 3382, 2971, 2918, 2840,
1615, 1590, 1461, 1380, 1216, 1175, 1146, 826, 750 cm-1;
1H NMR (CDCl3, 400 MHz) d 11.15 (2H, s, 2 9 OH),
7.94 (2H, dd, J = 1.3 and 8.0 Hz, H-5 and H-50), 7.85 (2H,
d, J = 9.0 Hz, H-4 and H-40), 7.44 (2H, m, H-7 and H-70),
7.38 (2H, m, H-6 and H-60), 7.24 (2H, d, J = 9.0 Hz, H-3
and H-30), 7.12 (2H, dd, J = 1.3 and 8.0 Hz, H-8 and
H-80); 13C NMR (CDCl3, 100 MHz) d 154.3 (C, C-2 and
C-20), 133.9 (C, C-8a and C-80a), 130.0 (CH, C-4 and C-40),
129.2 (C, C-4a and C-40a), 128.2 (CH, C-5 and C-50), 126.9
(CH, C-7 and C-70), 125.7 (CH, C-6 and C-60), 123.5 (CH,
C-8 and C-80), 118.4 (CH, C-3 and C-30), 110.8 (C, C-1 and
C-10); ESIMS m/z 286.10 [M]? (C20H14O2); Anal. Calc.
for C20H14O2: C, 83.90; H, 4.93; found: C, 84.88; H, 5.05.
3.4.3 1,3,8-Trihydroxy-6-methylanthracene-9,10-dione (3)
Orange coloured crystals; mp 267–269 C; IR (KBr) tmax
3510, 3056, 2918, 1676, 1625, 1565, 1458, 1371, 1272,
1205, 1161, 1082, 1026, 749 cm-1; 1H NMR (CDCl3,
400 MHz) d 12.13 (2H, s, 2 9 OH), 12.02 (1H, s, OH),
7.81 (1H, d, J = 1.2 Hz, H-2), 7.65 (1H, d, J = 1.2 Hz,
H-4), 7.30 (1H, d, J = 1.2 Hz, H-7), 7.09 (1H, d,
J = 1.2 Hz, H-5), 2.46 (3H, s, –CH3);
13C NMR (CDCl3,
100 MHz) d 192.5 (C = O, C-10), 182.0 (C = O, C-9),
162.6 (C, C-8), 162.4 (C, C-1), 160.3 (C, C-6), 149.3 (C,
C-3), 136.9 (CH, C-2), 134.0 (C, C-4a), 133.8 (C, C-5a),
124.5 (CH, C-4), 121.3 (CH, C-7), 119.9 (CH, C-5), 113.7
(C, C-8a), 111.8 (C, C-1a), 22.2 (CH3); ESIMS m/z 270.05
[M]? (C15H10O5); Anal. Calc. for C15H10O5: C, 66.67; H,
3.73; found: C, 67.58; H, 3.85.
3.4.4 5-Hydroxy-1,7-bis (4-hydroxy-3-
methoxyphenyl)hepta-1,4,6-trien-3-one (4)
Yellow-orange coloured crystals; mp 177 C; IR (KBr)
tmax 3427, 3065, 2905, 1682, 1605, 1480, 1120 cm
-1; 1H
Fig. 6 Interactions profile of a compound 3 and b compound 4 with receptor
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Fig. 7 HB plot of interacted
residues in protein with
compound 3 (a) and compound
4 (b)
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NMR (CDCl3, 400 MHz) d 11.12 (2H, s, 2 9 -OH), 10.75
(1H, s, -OH), 7.58 (1H, d, H-1), 7.22 (1H, d, H-2), 7.10
(2H, s, H-20 and H-200), 6.92 (2H, d, J = 8.0 Hz, H-50 and
H-500), 6.81 (2H, d, J = 8.0 Hz, H-60 and H-600), 6.72 (1H,
s, H-4), 6.65 (1H, d, H-6), 6.51 (1H, d, H-7), 3.85 (6H, s,
2 9 -OCH3);
13C NMR (CDCl3, 100 MHz) d 182.4 (C,
C-3), 180.3 (C, C-5), 149.6 (C, C-40 and C-400), 147.3 (C,
C-30 and C-300), 142.3 (CH, C-1), 140.7 (CH, C-7), 127.8
(C, C-10 and C-100), 124.8 (CH, C-2), 122.2 (CH, C-6),
121.9 (CH, C-60 and C-600), 116.5 (CH, C-50 and C-500),
111.2 (CH, C-20 and C-200), 100.1 (CH, C-4), 55.6 (2 9 -
OCH3); ESIMS m/z 368.13 [M]
? (C21H20O6); Anal. Calc.
for C21H20O6: C, 68.47; H, 5.47; found: C, 69.81; H, 5.85.
3.5 X-ray Crystallographic Analysis
The crystal structures of the compounds 2 and 4 were
determined by X-ray diffraction experiments performed on
a Bruker Apex II diffractometer. The diffraction data was
collected at room temperature 293(2) K using graphite
monochromated Mo Ka (k = 0.71073 A˚). Data reduction
was performed with APEX II [26]. Lorentz and polariza-
tion corrections were applied. Absorption corrections were
applied using SADABS [27]. An extinction correction was
applied during the refinement of the crystal structure of
compound 2 [28]. The crystallographic structures were
solved using direct methods (SHELXS-97) [28]. The
structure refinements were carried out with SHELXL-97
software [28]. The refinements were made by full-matrix
least-squares on F2, with anisotropic displacement param-
eters for all non-hydrogen atoms. All the hydrogen atoms
were located in a difference Fourier synthesis, placed at
calculated positions and then, included in the structure
factor calculation in a riding model using SHELXL-97
defaults with the exception of the hydrogen atoms bonded
to hetero atoms, which were refined freely. MERCURY 3.3
[29] was used for figure plotting. PLATON [30] was used
for data analysis. Additional information to the structures
determination is given in Table 1. Atomic coordinates,
thermal parameters and bond lengths and angles have been
deposited at the Cambridge Crystallographic Data Centre
(CCDC) with reference numbers 1463766 and 1463767.
3.6 DFT Calculations
The geometry optimizations were performed using the
GAMESS package [31], starting from the experimental
X-ray geometries. The calculations were performed within
density functional theory (DFT) using B3LYP (Becke
three-parameter Lee–Yang–Parr) for exchange and corre-
lation, which combines the hybrid exchange functional of
Becke [32, 33] with the correlation functional of Lee, Yang
and Parr [34]. The calculations were performed with an
extended 6-311G(d, p) basis set. Tight conditions for
convergence of both the self-consistent field cycles and the
maximum density and energy gradient variations were
imposed (10-5 atomic units). At the end of each geometry
optimization we conducted a Hessian calculation to guar-
antee that the final structure corresponds to a true mini-
mum, using the same level of theory as in the geometry
optimization.
3.7 In Vitro AChE Inhibition Study
All the isolated compounds (1–4) were assessed for AChE
inhibition study by Ellman’s method [35, 36]. AChE stock
solution was prepared by dissolving human recombinant
AChE (EC: 3.1.1.7) lyophilized powder (Sigma-Aldrich) in
0.1 M phosphate buffer (pH = 8.0) containing Triton
X-100 (0.1 %). Five increasing concentrations of test
compounds were assayed to obtain % inhibition of the
enzymatic activity in the range of 20–80. The assay solu-
tion consisted of a 0.1 M phosphate buffer pH 8.0, with the
addition of 340 lM 5,50-dithio-bis(2-nitrobenzoic acid),
0.02 unit per mL of human recombinant AChE from human
serum and 550 lM of the substrate (acetylthiocholine
iodide, ATCh). Increasing concentrations of the tested
inhibitor were added to the assay solution and pre-incu-
bated for 5 min at 37 C with the enzyme followed by the
addition of the substrate. Initial rate assays were performed
at 37 C using a Jasco V-530 double beam Spectropho-
tometer. The absorbance value at 412 nm was recorded for
5 min and enzyme activity was calculated from the slope of
the obtained linear trend. Assays were carried out with a
blank containing all components except AChE to account
for the non-enzymatic reaction. The reaction rates were
compared and the percent inhibition due to the presence of
tested inhibitors was calculated. Each concentration was
analysed in triplicate, and IC50 values were determined
graphically from log concentration-inhibition curves
(GraphPad Prism 4.03 software, GraphPad Software Inc.).
Tacrine was used as a standard inhibitor.
Table 5 In vivo cytotoxicity assay of isolated compounds (1–4)
S. no. Compound LD50 value (lg/mL)
1 Compound 1 23.40 ± 0.02
2 Compound 2 17.78 ± 0.05
3 Compound 3 13.80 ± 0.03
4 Compound 4 11.66 ± 0.04
5 Vincristine sulphate (Standard) 8.84 ± 0.01
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3.8 Molecular Docking
Docking simulations of compounds 3 and 4 were carried
out according to the method described previously [37, 38].
The energy minimized structure of compounds 3 and 4 was
sketched with ChemDraw Ultra (2D and 3D). The coor-
dinates of compounds 3 and 4 was checked using
PRODRG program [39] for generating molecular topolo-
gies. The three-dimensional structures of target protein
function as a receptor (PDB: 1EVE) and was retrieved
from the protein data bank. All the heteroatoms coupled
with proteins including water molecules, bound ligands and
any co-crystallized solvent were discarded from the PDB
file and the missing assignments like proper bonds, bond
orders, hybridization and charges were assigned using the
Molegro Virtual Viewer [40]. PATCHDOCK [41],
iGEMDOCK [42] and Acceryl Discovery Studio 4.0 Client
[43] were employed to evaluate the molecular docking,
energy profile and visualization of compounds-receptor
interactions, respectively.
3.9 In Vivo Cytotoxicity Assay
Brine shrimp lethality bioassay is commonly used in the
bioassay for the bioactive compounds [44, 45]. The
in vivo cytotoxicity assay was performed on brine
shrimp nauplii (Artemia salina) in accordance with the
Mayer method [46]. The egg of brine shrimp were
hatched in a tank filled with artificially prepared sea
water (brine, 3.8 % NaCl) exposed to incandescent light.
Air was supplied at the bottom of the tank with the help
of air supplier fitted with tube to keep the shrimps in
uniform motion. The assay was performed 24 h after
hatching and no food supplement was given during the
hatching and experimental periods. A test sample
(5.0 mg) was dissolved in 1 mL DMSO to obtain stock
solution of 5 mg/mL. Different concentrations of test
samples were obtained from stock solution and placed in
separate vials, and the volume of each vial was made up
to 5 mL with brine to obtain the desired final concen-
trations (10, 20, 40, 60 and 80 lg/mL). The negative
control was prepared in the same manner without the
samples. Vincristine sulphate was used as a standard
anti-cancer drug. Thirty brine shrimp nauplii were then
placed in each vial. After 24 h of incubation, the vials
were observed using a magnifying glass, and the number
of survivors in each vial were counted and noted. The
LD50 values were calculated using the plot of percentage
of mortality and logarithm of concentration. All tests
were performed in triplicate and expressed as mean.
4 Conclusion
This is the first report of the isolation of these four com-
pounds from Clutia lanceolata leaves viz. 3,4-dihydroxy-2-
methylbenzoic acid (1), 2,20-dihydroxy-1,10-binaphthyl (2),
1,3,8-trihydroxy-6-methylanthracene-9,10-dione (3) and
5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,
6-trien-3-one (4). Molecular structure of compounds 2 and
4 was authenticated unambiguously by X-ray crystallog-
raphy and DFT studies. All the isolated compounds (1–4)
showed significant activity for cytotoxicity and AChE
inhibition assay. Compound 4 showed significant lethality
to the brine shrimp nauplii. As far as AChE inhibition
concerned, compounds 3 and 4 acted as potent enzyme
inhibitors. Molecular docking study validated the binding
pattern and extent of binding of compounds 3 and 4 with
the target enzymes.
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